Clinical Trials Browser

Interventional × mirdametinib × Gastrointestinal × Clear all

NCT02039336 2025-07-08

M13DAP

Phase 1/2 Completed

Gastrointestinal

Colorectal Neoplasms

NCT02510001 2021-07-13

MErCuRIC1

Phase 1 Completed

82 enrolled 36 charts

Gastrointestinal

Colorectal Neoplasms

NCT00147550 2013-09-13

MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.

Phase 1/2 Terminated

BreastDermatologicGastrointestinal

Breast Neoplasms, Colonic Neoplasms, Melanoma